[1]刘倩楠聂静张振伟尹畅.单病种过程质量评价现状及思考[J].中国卫生质量管理,2022,29(07):008-11.[doi:10.13912/j.cnki.chqm.2022.29.7.03 ]
 LIU Qiannan,NIE Jing,ZHANG Zhenwei.The Status and Thinking of Process Quality Evaluation of Single Disease[J].Chinese Health Quality Management,2022,29(07):008-11.[doi:10.13912/j.cnki.chqm.2022.29.7.03 ]
点击复制

单病种过程质量评价现状及思考
分享到:

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第29卷
期数:
2022年07期
页码:
008-11
栏目:
特别关注
出版日期:
2022-07-28

文章信息/Info

Title:
The Status and Thinking of Process Quality Evaluation of Single Disease
作者:
刘倩楠聂静张振伟尹畅
国家卫生健康委医院管理研究所医疗质量监测与控制研究室
Author(s):
LIU QiannanNIE JingZHANG Zhenwei
Medical Quality Monitoring and Control Laboratory, National Institute of Hospital Administration
关键词:
单病种过程质量质量评价医疗质量
Keywords:
Single Disease Process Quality Quality Evaluation Medical Quality
分类号:
R197
DOI:
10.13912/j.cnki.chqm.2022.29.7.03
文献标志码:
A
摘要:
通过检索文献,梳理国内外单病种过程质量评价现状,阐述了单病种过程质量评价的特征和方法。我国目前尚未形成单病种过程质量评价体系,但具备良好的过程质量数据基础。下一步需开发符合我国实际的单病种过程质量评价体系,并落实奖惩,以促进医疗质量持续改进。
Abstract:
Through the retrieval of literatures, the present situation of process quality evaluation of single disease was summarized, and the characteristics and methods of process quality evaluation of single disease were described. The quality evaluation system of single disease was not yet formed in China, but it had good process quality data base. The next step was to develop a single disease process quality evaluation system in line with China's reality, to implement reward and punishment measures to promote continuous improvement of medical quality.

参考文献/References:

[1]Premier,Center for Medicare & Medicaid Services,Department of Health and Human Services (HHS),USA.Premier hospital quality incentive demonstration[EB/OL]. (2020-11-02) [2021-04-15].https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instr-uments/HospitalQualityInits/HospitalPr-emier. [2]王吉善,张振伟.开展病种质量管理提高医疗服务水平[J].中国医院,2010,14(5):2-3. [3]朱 婷,姜焰凌,谢颖夫,等.新形势下单病种质量管理解读与探索[J].卫生软科学,2011,25(9):624-626. [4]Center for Medicare & Medicaid Services/Hospital Quality Incentive Demonstration Project.Project overview and findings from year one[EB/OL].(2006-04-13)[2021-06-16].https://assets.hcca-info.org/Portals/0/PDFs/Resources/Conference_Handouts/Compliance_Institute/2007/307-2.pdf. [5]The Joint Commission. History of performance measures [EB/OL]. (2006-04-13)[2021-06-16]. https://www.jointcommission.org/measurement/measures. [6]The Joint Commission. International library of measures [EB/OL]. [2021-09-16].https://www.scribd.com/doc/212801420/JCI-International-Library-of-Measures. [7]The Joint Commission. Specifications manual for joint commission national quality measures[EB/OL].(2020-09-25)[2021-10-16].https://manual.jointcommission.org/pub/Manual/ReleaseNotesArchive/TJC_v2021A1.pdf. [8]SUTTON M,NIKOLOVA S,BOADEN R,et al.Reduced morality with hospital pay for performance in England[J].The New England Journal of Medicine,2012,367:1821-1828. [9]卫生部办公厅.第一批单病种质量控制指标的通知:卫办医政函〔2009〕425号[Z].2009. [10]卫生部办公厅.第二批单病种质量控制指标的通知:卫办医政函〔2010〕909号[Z].2010. [11]卫生部办公厅.第三批单病种质量控制指标的通知:卫办医政函〔2012〕376号[Z].2012. [12]国家卫生健康委员会.国家卫生健康委办公厅关于进一步加强单病种质量管理与控制工作的通知:国卫办医函〔2020〕624号[EB/OL].(2020-07-23)[2021-04-06]. http://www.nhc.gov.cn/yzygj/s7657/202007/b31755433b8e4a50b23906b9f1a07393.shtml.[13]刘红梅,解 翠,张玉莲,等.单病种护理质量标准在急性心肌梗死患者中的应用[J].中国卫生质量管理,2016,23(5):60-63. [14]姚 瑶,李 妙,袁 方,等.强化单病种质量控制 提高医疗质量[J].中国卫生质量管理,2010,17(2):24-27. [15]解晓明,高卓平,刘立平,等.单病种质量管理的实践与思考[J].中国卫生质量管理,2012,19(1):17-19. [16]莫春梅,杨天桂,石应康.单病种平均住院日及住院费用关系研究[J].中国卫生质量管理,2017,17(6):57-60. [17]刘雯薇,杨 静,袁素维,等.单病种质量控制前后髋关节置换术住院患者的住院日和住院费用评价[J].中国卫生统计,2016,33(2):287-289,292. [18]帕提古丽·尼亚孜,周国栋,郭建新.脑梗死单病种过程质量管理评价分析[J].中国病案,2015,16(5):92-94. [19]莫夏丽.督查反馈表在社区获得性肺炎质量管理中的应用[J].中国医疗管理科学,2016,6(3):65-67. [20]李 琳.运用秩和比法对单病种医疗质量进行评价[J].中国卫生统计,2019,36(6):930-931. [21]徐 盼,宋 斌.单病种质量监测算法机在医疗系统中的应用[J].现代计算机,2020(16):42-45,54. [22]孙佳璐,杨昕,李子孝,等.我国脑梗死质量管理的历史演变[J].中国卫生质量管理,2021,28(8):15-18. [23]国家卫生健康委医政医管局.2020年国家医疗服务与质量安全报告[M].北京:科学技术出版社,2021:414-499. [24]Premier Hospital Quality Incentive Demonstration Rewarding Superior Quality Care FACT SHEET[EB/OL].[2021-08-16].https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Downloads/HospitalPremierPressRelease-FactSheet.pdf.

相似文献/References:

[1]刘红梅解翠张玉莲李媛孙杨周忠良刘晓梅.单病种护理质量标准在急性心肌梗死患者中的应用[J].中国卫生质量管理,2016,23(05):060.[doi:10.13912/j.cnki.chqm.2016.23.5.18]
[2]赵素平 姚溪 张玉莲 高京华.单病种护理质量标准在老年消化性溃疡患者中的应用[J].中国卫生质量管理,2017,24(05):078.[doi:10.13912/j.cnki.chqm.2017.24.5.25]
[3]吴越 李恒新 张雅娟 李刚 刘南 高建民.单病种精细化防治效果分析:以狂犬病为例[J].中国卫生质量管理,2017,24(06):109.[doi:10.13912/j.cnki.chqm.2017.24.6.36]
[4]曾慧慧蒋荣猛马旭东.我国单病种质量管理历史沿革及思考[J].中国卫生质量管理,2021,28(10):021.[doi:10.13912/j.cnki.chqm.2021.28.10.06 ]
 ZENG Huihui,JIANG Rongmeng,MA Xudong.Historical Evolution and Thinking of Single Disease Quality Management in China[J].Chinese Health Quality Management,2021,28(07):021.[doi:10.13912/j.cnki.chqm.2021.28.10.06 ]
[5]尹畅王建伟张超黎张振伟马旭东.医疗机构落实国家单病种质量管理工作的思路探讨[J].中国卫生质量管理,2022,29(07):005.[doi:10.13912/j.cnki.chqm.2022.29.7.02 ]
 YIN Chang,WANG Jianwei,ZHANG Chaoli.Discussion on Working Ideas for Medical Institutions in Implementing Single Disease Quality Management[J].Chinese Health Quality Management,2022,29(07):005.[doi:10.13912/j.cnki.chqm.2022.29.7.02 ]
[6]尹畅王建伟刘倩楠张勤张振伟马旭东.以单病种过程质量管理促进临床诊疗同质化[J].中国卫生质量管理,2022,29(07):012.[doi:10.13912/j.cnki.chqm.2022.29.7.04 ]
 YIN Chang,WANG Jianwei,LIU Qiannan.Promoting Homogenization of Clinical Diagnosis and Treatment by Process Quality Management of Single Disease[J].Chinese Health Quality Management,2022,29(07):012.[doi:10.13912/j.cnki.chqm.2022.29.7.04 ]
[7]徐莉顾逸君邵琰婷张涛.单病种质量管理信息化平台建设与应用[J].中国卫生质量管理,2022,29(07):015.[doi:10.13912/j.cnki.chqm.2022.29.7.05 ]
 XU Li,GU Yijun,SHAO Yanting.Construction and Application of Single Disease Quality Management Informatization Platform[J].Chinese Health Quality Management,2022,29(07):015.[doi:10.13912/j.cnki.chqm.2022.29.7.05 ]
[8]潘伟华许健穆嘉盛黄宇飞沈鸿楼汪鑫欧阳田岽.应用人工智能提升单病种质量管理水平[J].中国卫生质量管理,2022,29(07):019.[doi:10.13912/j.cnki.chqm.2022.29.7.06 ]
 PAN Weihua,XU Jian,MU Jiasheng.Improving the Quality Management Level of Single Disease Through Artificial Intelligence[J].Chinese Health Quality Management,2022,29(07):019.[doi:10.13912/j.cnki.chqm.2022.29.7.06 ]
[9]邓明时黎明林伟龙杨谨成安宇杨娟周成诚杨文静.我国肿瘤单病种质控路径实践与展望[J].中国卫生质量管理,2022,29(11):006.[doi:10.13912/j.cnki.chqm.2022.29.11.02 ]
 DENG Ming,SHI Liming,LIN Weilong.Practice and Prospect of Quality Control Path of Single Disease of Tumor in China[J].Chinese Health Quality Management,2022,29(07):006.[doi:10.13912/j.cnki.chqm.2022.29.11.02 ]
[10]郑莹王泽洲吴炅.基于单病种数据库的临床科研平台构建探索[J].中国卫生质量管理,2023,30(07):030.[doi:10.13912/j.cnki.chqm.2023.30.7.07 ]
 ZHENG Ying,WANG Zezhou,WU Jiong.Construction of Clinical Research Platform Based on Specialized Disease Database[J].Chinese Health Quality Management,2023,30(07):030.[doi:10.13912/j.cnki.chqm.2023.30.7.07 ]
[11]马旭东王建伟张超黎张振伟尹畅.我国单病种质量管理工作回顾及思考[J].中国卫生质量管理,2022,29(07):001.[doi:10.13912/j.cnki.chqm.2022.29.7.01 ]
 MA Xudong,WANG Jianwei,ZHANG Chaoli.Review and Thinking on the Quality Management of Single Disease in China[J].Chinese Health Quality Management,2022,29(07):001.[doi:10.13912/j.cnki.chqm.2022.29.7.01 ]

更新日期/Last Update: 2022-07-28